{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:39:22Z","timestamp":1783489162125,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:00:00Z","timestamp":1714176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.eprac.2024.04.017","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T16:48:44Z","timestamp":1714495724000},"page":"770-778","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Eye-Related Adverse Events After I-131 Radioiodine Therapy: A Systematic Review of the Current Literature"],"prefix":"10.1016","volume":"30","author":[{"given":"Elham","family":"Rahmanipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emran","family":"Askari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ghorbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahyar","family":"Daskareh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2271-9764","authenticated-orcid":false,"given":"Seyed Ali","family":"Mirshahvalad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10061","key":"10.1016\/j.eprac.2024.04.017_bib1","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1016\/S0140-6736(16)30172-6","article-title":"Thyroid cancer","volume":"388","author":"Cabanillas","year":"2016","journal-title":"Lancet"},{"issue":"9356","key":"10.1016\/j.eprac.2024.04.017_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0140-6736(03)12488-9","article-title":"Thyroid carcinoma","volume":"361","author":"Sherma","year":"2003","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.eprac.2024.04.017_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4103\/apjon.apjon_23_17","article-title":"Seeking optimal management for radioactive iodine therapy-induced adverse effects","volume":"4","author":"Charalambous","year":"2017","journal-title":"Asia Pac J Oncol Nurs"},{"issue":"3","key":"10.1016\/j.eprac.2024.04.017_bib4","first-page":"127","article-title":"Side effects of high-dose radioactive iodine for ablation or treatment of differentiated thyroid carcinoma","volume":"8","author":"Chow","year":"2005","journal-title":"Hong Kong J Radiol"},{"key":"10.1016\/j.eprac.2024.04.017_bib5","first-page":"4178","article-title":"Analysis of human sodium iodide symporter immunoreactivity in human exocrine glands","volume":"84","author":"Spitzweg","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.eprac.2024.04.017_bib6","doi-asserted-by":"crossref","first-page":"T167","DOI":"10.1530\/ERC-21-0035","article-title":"Na+\/I\u2212 symporter expression, function, and regulation in non-thyroidal tissues and impact on thyroid cancer therapy","volume":"28","author":"Jhiang","year":"2021","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1016\/j.eprac.2024.04.017_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American thyroid association management guidelines for Adult patients with thyroid Nodules and differentiated thyroid cancer: the American thyroid association guidelines Task Force on thyroid Nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.04.017_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s42000-021-00304-3","article-title":"Sialadenitis as a complication of radioiodine therapy in patients with thyroid cancer: where do we stand?","volume":"20","author":"Adramerinas","year":"2021","journal-title":"Hormones (Athens)"},{"key":"10.1016\/j.eprac.2024.04.017_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.960265","article-title":"Prevention of salivary gland dysfunction in patients treated with radioiodine for differentiated thyroid cancer: a systematic review of randomized controlled trials","volume":"13","author":"Auttara-Atthakorn","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.eprac.2024.04.017_bib10","first-page":"2479","article-title":"Nasolacrimal duct obstruction following radioactive iodine 131 therapy in differentiated thyroid cancers: review of 19 cases","volume":"8","author":"Al-Qahtani","year":"2014","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"10.1016\/j.eprac.2024.04.017_bib11","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1080\/02713683.2021.1878229","article-title":"Clinical and demographic characteristics of tearing in patients after radioiodine ablation for differentiated thyroid cancer","volume":"46","author":"Yartsev","year":"2021","journal-title":"Curr Eye Res"},{"issue":"1","key":"10.1016\/j.eprac.2024.04.017_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/IOP.0000000000000603","article-title":"Iodine-131 therapy and lacrimal drainage system toxicity: nasal localization studies using whole body nuclear scintigraphy and SPECT-CT","volume":"33","author":"Ali","year":"2017","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.eprac.2024.04.017_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.IOP.0000117340.41849.81","article-title":"Nasolacrimal obstruction secondary to I131 therapy","volume":"20","author":"Burns","year":"2004","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"12","key":"10.1016\/j.eprac.2024.04.017_bib14","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1089\/thy.2015.0657","article-title":"Lacrimal system obstruction after radioiodine therapy in differentiated thyroid carcinomas: a prospective comparative study","volume":"26","author":"da Fonseca","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.04.017_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s11764-020-00897-5","article-title":"Looking under the hood of \u201cthe Cadillac of cancers:\u201d radioactive iodine-related craniofacial side effects among patients with thyroid cancer","volume":"14","author":"Diamond-Rossi","year":"2020","journal-title":"J\u00a0Cancer Surviv"},{"issue":"10","key":"10.1016\/j.eprac.2024.04.017_bib16","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1097\/MNM.0b013e3283570fb8","article-title":"Nasolacrimal duct obstruction as a complication of iodine-131 therapy in patients with thyroid cancer","volume":"33","author":"Fard-Esfahani","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.eprac.2024.04.017_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/2586512","article-title":"Radioactive iodine administration is associated with persistent related symptoms in patients with differentiated thyroid cancer","volume":"2016","author":"Florenzano","year":"2016","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.eprac.2024.04.017_bib18","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00259-002-0969-0","article-title":"Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study","volume":"29","author":"Zettinig","year":"2002","journal-title":"Eur J Nucl Med Mol Imag"},{"issue":"12","key":"10.1016\/j.eprac.2024.04.017_bib19","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1210\/jc.2002-020210","article-title":"Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma","volume":"87","author":"Kloos","year":"2002","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.eprac.2024.04.017_bib20","first-page":"738","article-title":"Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy","volume":"42","author":"Solans","year":"2001","journal-title":"J\u00a0Nucl Med"},{"issue":"12","key":"10.1016\/j.eprac.2024.04.017_bib21","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.eprac.2022.08.006","article-title":"Factors associated with radioactive iodine therapy\u2013acquired nasolacrimal duct obstruction","volume":"28","author":"Lee","year":"2022","journal-title":"Endocr Pract"},{"issue":"4","key":"10.1016\/j.eprac.2024.04.017_bib22","first-page":"13","article-title":"Lacrimal system pathology in patients with malignant thyroid tumors after radioactive iodine therapy, and its correction methods","volume":"10","author":"Beldovskaya","year":"2017","journal-title":"Ophthalmology J"},{"issue":"2","key":"10.1016\/j.eprac.2024.04.017_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejr.2011.03.007","article-title":"Sj\u00f6gren syndrome and fibromyalgia after radioiodine therapy in cancer thyroid patients","volume":"33","author":"Gheita","year":"2011","journal-title":"Egypt Rheumatol"},{"issue":"5","key":"10.1016\/j.eprac.2024.04.017_bib24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1089\/thy.2021.0418","article-title":"Surgical risk prediction for nasolacrimal duct obstruction in radioactive iodine-treated thyroid cancer: a Nationwide Cohort Study","volume":"32","author":"Lee","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.04.017_bib25","article-title":"Clinical characteristics of nasolacrimal duct obstruction after iodine therapy in differentiated thyroid cancer patients","author":"Li","year":"2023","journal-title":"Ear Nose Throat J"},{"issue":"12","key":"10.1016\/j.eprac.2024.04.017_bib26","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1089\/thy.2014.0162","article-title":"Nasal symptoms after radioiodine therapy: a rarely described side effect with similar frequency to lacrimal dysfunction","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.eprac.2024.04.017_bib27","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4274\/mirt.33042","article-title":"The effect of high dose radioiodine therapy on formation of radiation retinopathy during thyroid cancer treatment","volume":"23","author":"G\u00fcveli","year":"2014","journal-title":"Mol Imaging Radionucl Ther"},{"issue":"48","key":"10.1016\/j.eprac.2024.04.017_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005474","article-title":"Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer","volume":"95","author":"Louvet","year":"2016","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.eprac.2024.04.017_bib29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1007\/s00259-015-3055-0","article-title":"131 I treatment for thyroid cancer and the risk of developing salivary and lacrimal gland dysfunction and a second primary malignancy: a nationwide population-based cohort study","volume":"42","author":"Ko","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.eprac.2024.04.017_bib30","first-page":"319","article-title":"Evaluation the early effects of single high dose radioiodine therapy on lacrimal gland function","volume":"12","author":"GEDIK","year":"2014","journal-title":"Int J Radiat Res"},{"issue":"5","key":"10.1016\/j.eprac.2024.04.017_bib31","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1089\/thy.2012.0050","article-title":"Salivary and lacrimal gland dysfunction after remnant ablation with radioactive iodine in patients with differentiated thyroid carcinoma prepared with recombinant human thyrotropin","volume":"23","author":"Rosario","year":"2013","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.eprac.2024.04.017_bib32","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/RLU.0b013e318124fdb6","article-title":"The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma","volume":"32","author":"Fard-Esfahani","year":"2007","journal-title":"Clin Nucl Med"},{"issue":"9","key":"10.1016\/j.eprac.2024.04.017_bib33","first-page":"1551","article-title":"Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma","volume":"39","author":"Alexander","year":"1998","journal-title":"J\u00a0Nucl Med"},{"issue":"12","key":"10.1016\/j.eprac.2024.04.017_bib34","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1002\/hed.24895","article-title":"Correlation among ocular surface disease, xerostomia, and nasal symptoms in patients with differentiated thyroid carcinoma subjected to radioiodine therapy: a prospective comparative study","volume":"39","author":"da Fonseca","year":"2017","journal-title":"Head Neck"},{"issue":"6","key":"10.1016\/j.eprac.2024.04.017_bib35","doi-asserted-by":"crossref","first-page":"836","DOI":"10.2967\/jnumed.115.167197","article-title":"Association between 131I treatment for thyroid cancer and risk of receiving cataract surgery: a cohort study from Taiwan","volume":"57","author":"Lin","year":"2016","journal-title":"J\u00a0Nucl Med"},{"issue":"9","key":"10.1016\/j.eprac.2024.04.017_bib42","first-page":"1100","article-title":"Dysfunction of the salivary and lacrimal glands after radioiodine therapy for thyroid cancer: results of the START study after 6-months of follow-up","volume":"33","author":"Baudin","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/j.eprac.2024.04.017_bib41","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1186\/s12889-022-14491-0","article-title":"Global, regional, national burden and gender disparity of cataract: findings from the global burden of disease study 2019","volume":"22","author":"Fang","year":"2022","journal-title":"BMC Publ Health"},{"issue":"5","key":"10.1016\/j.eprac.2024.04.017_bib36","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.iop.0000179369.75569.a8","article-title":"Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients","volume":"21","author":"Morgenstern","year":"2005","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.eprac.2024.04.017_bib37","first-page":"241","article-title":"Susceptibility of Candida albicans to peroxidase-catalyzed oxidation products of thiocyanate, iodide and bromide","volume":"20","author":"Majerus","year":"1992","journal-title":"J\u00a0Biol Buccale"},{"issue":"4","key":"10.1016\/j.eprac.2024.04.017_bib38","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/IOP.0000000000000647","article-title":"Iodine-131 therapy and nasolacrimal duct obstructions: what We Know and what We need to Know","volume":"32","author":"Ali","year":"2016","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/j.eprac.2024.04.017_bib39","article-title":"Corneal ulcers with non-infectious appearance caused by nasolacrimal duct obstruction or canaliculitis","volume":"27","author":"Ishimoto","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"11","key":"10.1016\/j.eprac.2024.04.017_bib40","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1002\/hed.26417","volume":"42","author":"Singer","year":"2020","journal-title":"Head Neck"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2400507X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2400507X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T01:34:32Z","timestamp":1722562472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2400507X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1530891X2400507X"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.04.017","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eye-Related Adverse Events After I-131 Radioiodine Therapy: A Systematic Review of the Current Literature","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}